Your browser doesn't support javascript.
loading
Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome.
Vieira, Jacob; Gallagher, Tara; Sui, Hui-Yu; Jesudasen, Sirus; Whiteson, Katrine; O'Toole, George A; Hanselmann, Kurt; Lai, Peggy S.
Affiliation
  • Vieira J; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital.
  • Gallagher T; Department of Molecular Biology & Biochemistry, University of California, Irvine.
  • Sui HY; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital.
  • Jesudasen S; Department of Medicine, Massachusetts General Hospital.
  • Whiteson K; Department of Molecular Biology & Biochemistry, University of California, Irvine.
  • O'Toole GA; Department of Microbiology & Immunology, Geisel School of Medicine at Dartmouth.
  • Hanselmann K; Swiss i-research and teaching institute.
  • Lai PS; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital; plai@mgh.harvard.edu.
J Vis Exp ; (174)2021 08 03.
Article in En | MEDLINE | ID: mdl-34424248
ABSTRACT
Airway microbial communities are thought to play an important role in the progression of cystic fibrosis (CF) and other chronic pulmonary diseases. Microbes have traditionally been classified based on their ability to use or tolerate oxygen. Supplemental oxygen is a common medical therapy administered to people with cystic fibrosis (pwCF); however, existing studies on oxygen and the airway microbiome have focused on how hypoxia (low oxygen) rather than hyperoxia (high oxygen) affects the predominantly aerobic and facultative anaerobic lung microbial communities. To address this critical knowledge gap, this protocol was developed using an artificial sputum medium that mimics the composition of sputum from pwCF. The use of filter sterilization, which yields a transparent medium, allows optical methods to follow the growth of single-celled microbes in suspension cultures. To create hyperoxic conditions, this model system takes advantage of established anaerobic culturing techniques to study hyperoxic conditions; instead of removing oxygen, oxygen is added to cultures by daily sparging of serum bottles with a mixture of compressed oxygen and air. Sputum from 50 pwCF underwent daily sparging for a 72-h period to verify the ability of this model to maintain differential oxygen conditions. Shotgun metagenomic sequencing was performed on cultured and uncultured sputum samples from 11 pwCF to verify the ability of this medium to support the growth of commensal and pathogenic microbes commonly found in cystic fibrosis sputum. Growth curves were obtained from 112 isolates obtained from pwCF to verify the ability of this artificial sputum medium to support the growth of common cystic fibrosis pathogens. We find that this model can culture a wide variety of pathogens and commensals in CF sputum, recovers a community highly similar to uncultured sputum under normoxic conditions, and creates different culture phenotypes under varying oxygen conditions. This new approach might lead to a better understanding of unanticipated effects induced by the use of oxygen in pwCF on airway microbial communities and common respiratory pathogens.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Microbiota Type of study: Guideline Limits: Humans Language: En Journal: J Vis Exp Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Microbiota Type of study: Guideline Limits: Humans Language: En Journal: J Vis Exp Year: 2021 Document type: Article